Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Mathian

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Journal of the American Academy of Dermatology|March 6, 2023
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosusFrançois Chasset, Léa Jaume, Alexis Mathian, et al.
Atherosclerosis|November 6, 2025
Assessment of the 2025 EAS clinical staging system for cardiometabolic disorders in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cellsHélène Le Buanec, Marie-Lise Gougeon, Alexis Mathian, et al.
Rheumatology (Oxford, England)|October 29, 2024
Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patientsMatthias Papo, Pierre Cappy, Alexandre Degachi, et al.
Annals of the Rheumatic Diseases|October 2, 2019
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of Intensive Care|February 9, 2021
Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenationPierre Bay, Guillaume Lebreton, Alexis Mathian, et al.
Joint Bone Spine|July 4, 2024
Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawalLudovic Trefond, Alexis Mathian, Raphael Lhote, et al.
Immunity|May 26, 2009
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factorMakoto Miyara, Yumiko Yoshioka, Akihiko Kitoh, et al.
British Journal of Haematology|October 15, 2021
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryThibault Comont, Mael Heiblig, Etienne Rivière, et al.
Seminars in Arthritis and Rheumatism|February 23, 2024
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patientsLudovic Trefond, Raphael Lhote, Alexis Mathian, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Journal of the American Academy of Dermatology|March 6, 2023
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosusFrançois Chasset, Léa Jaume, Alexis Mathian, et al.
Atherosclerosis|November 6, 2025
Assessment of the 2025 EAS clinical staging system for cardiometabolic disorders in systemic lupus erythematosusLévi-Dan Azoulay, Nadjia Kachenoura, Samia Boussouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cellsHélène Le Buanec, Marie-Lise Gougeon, Alexis Mathian, et al.
Rheumatology (Oxford, England)|October 29, 2024
Lymphadenopathy in systemic lupus erythematosus: no microbial trigger found by shotgun metagenomics in a retrospective study on 38 patientsMatthias Papo, Pierre Cappy, Alexandre Degachi, et al.
Annals of the Rheumatic Diseases|October 2, 2019
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Annals of Intensive Care|February 9, 2021
Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenationPierre Bay, Guillaume Lebreton, Alexis Mathian, et al.
Joint Bone Spine|July 4, 2024
Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawalLudovic Trefond, Alexis Mathian, Raphael Lhote, et al.
Immunity|May 26, 2009
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factorMakoto Miyara, Yumiko Yoshioka, Akihiko Kitoh, et al.
British Journal of Haematology|October 15, 2021
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryThibault Comont, Mael Heiblig, Etienne Rivière, et al.
Seminars in Arthritis and Rheumatism|February 23, 2024
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patientsLudovic Trefond, Raphael Lhote, Alexis Mathian, et al.
Pageof 22